Purdue Pharma LP won court approval to exit bankruptcy, capping six years of legal wrangling over a multibillion-dollar ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer ...

Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of ...

Today is a landmark day, representing the culmination of a six-year bankruptcy and mediation process,” said Steve Miller, Purdue Board Chairman. “The Plan is the product of intense work with our ...

A federal bankruptcy judge said on Friday he will approve a restructuring plan for drugmaker Purdue Pharma that includes a $7 ...

OxyContin maker Purdue Pharma urged a bankruptcy judge on Wednesday to approve a restructuring plan that includes a $7.4 ...

Purdue Pharma’s bankruptcy plan was approved by a federal judge Sept. 1, meaning the company that made and marketed the opioid Oxycontin will be dissolved, The New York Times reported. Judge Robert ...

Purdue Pharma won bankruptcy court approval for an opioid-related settlement of at least $7.4 billion, clearing a path for ...

Purdue and other opioid makers and distributors were accused of encouraging free-wheeling prescription of their products ...

If U.S. Bankruptcy Judge Sean Lane abides, it will close a long chapter — and maybe the entire book — on a legal odyssey over ...

A majority of Purdue Pharma’s more than 120,000 creditors have voted to approve the company’s bankruptcy plan, The New York Times reported July 27. Ninety-five percent of cities, states, tribes, ...

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...